IDEXX Laboratories, Inc. (IDXX)

478.74 +3.71 (+0.78%) At close: 04:00PM EDT

IDEXX Laboratories, Inc.

One IDEXX Drive
Westbrook, ME 04092
United States
207 556 0300
https://www.idexx.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 10,780

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jonathan J. Mazelsky	Pres, CEO & Director	3.07M	12.86M	1961
Mr. Brian P. McKeon	Exec. VP & CFO	1.43M	26.11M	1962
Mr. James F. Polewaczyk	Exec. VP & Chief Commercial Officer	1.19M	5.61M	1964
Mr. Michael J. Lane	Exec. VP and GM of Reference Laboratories & Information Technology	1.19M	4.05M	1968
Dr. Nimrata Khatra Hunt P.E., Ph.D.	Exec. VP of Strategy, Sector Devel. & Global Operations	1.18M	946.84k	1969
Mr. John Hart	Sr. VP of Global Operations	N/A	N/A	N/A
Mr. Jeffery D. Chadbourne	Sr. Director of Accounting & Financial Reporting	N/A	N/A	1976
Dr. Martin Smith Ph.D.	Exec. VP & CTO	N/A	N/A	1968
Mr. Ken Grady	Sr. VP & Chief Information Officer	N/A	N/A	N/A
Ms. Sharon E. Underberg	Exec. VP, Gen. Counsel, & Corp. Sec.	N/A	N/A	1961

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Corporate governance

IDEXX Laboratories, Inc.’s ISS governance QualityScore as of 1 March 2023 is 6. The pillar scores are Audit: 8; Board: 2; Shareholder rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.